Publication Name	World Journal of Diabetes
Manuscript ID	92914
Country	Spain

Received	2024-02-10 16:49
Peer-Review Started	2024-02-10 16:49
To Make the First Decision
Return for Revision	2024-03-05 02:55
Revised	2024-03-18 15:21
Second Decision	2024-04-22 02:53
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-04-22 06:16
Articles in Press	2024-04-22 06:16
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-05-31 06:25
Publish the Manuscript Online	2024-07-08 07:49

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Editorial
Article Title	MicroRNA-630: A promising avenue for alleviating inflammation in diabetic kidney disease
Manuscript Source	Invited Manuscript
All Author List	Javier Donate-Correa, Ainhoa González-Luis, Jésica Díaz-Vera and Juan Ramón Hernandez-Fernaud
ORCID	Author(s) ORCID Number Javier Donate-Correa http://orcid.org/0000-0001-7389-7347
Funding Agency and Grant Number
Corresponding Author	Javier Donate-Correa, PhD, Research Scientist, Teacher, Research Unit, University Hospital Nuestra Señora de Candelaria (UHNSC), Carretera del Rosario S/N, Santa Cruz de Tenerife 38010, Spain. jdonatecorrea@gmail.com
Key Words	Diabetes; Diabetic kidney disease; Inflammation; Toll-like receptor 4; microRNA-630
Core Tip	Targeting Toll-like receptors (TLRs) via microRNAs is a promising therapeutic approach for reducing inflammation and slowing the progression of diabetic kidney disease (DKD). Understanding how TLR4 expression and signaling are linked to microRNAs regulation, may pave the path for future targeted clinical interventions in DKD.
Publish Date	2024-07-08 07:49
Citation	<p>Donate-Correa J, González-Luis A, Díaz-Vera J, Hernandez-Fernaud JR. MicroRNA-630: A promising avenue for alleviating inflammation in diabetic kidney disease. <i>World J Diabetes</i> 2024; 15(7): 1398-1403</p>
URL	https://www.wjgnet.com/1948-9358/full/v15/i7/1398.htm
DOI	https://dx.doi.org/10.4239/wjd.v15.i7.1398

Full Article (PDF)	WJD-15-1398-with-cover.pdf
Manuscript File	92914_Auto_Edited-YJP.docx
Answering Reviewers	92914-answering-reviewers.pdf
Audio Core Tip	92914-audio.m4a
Conflict-of-Interest Disclosure Form	92914-conflict-of-interest-statement.pdf
Copyright License Agreement	92914-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	92914-non-native-speakers.pdf
Peer-review Report	92914-peer-reviews.pdf
Scientific Misconduct Check	92914-scientific-misconduct-check.png
Scientific Editor Work List	92914-scientific-editor-work-list.pdf
CrossCheck Report	92914-crosscheck-report.pdf
CrossCheck Report	92914-crosscheck-report.png